1-7 of 7
Alan K. Ikeda
Close
Sort by
Journal Articles

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

Clinical Trials & Observations
Bryanna Reinhardt, Omar Habib, Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino, Dayna Terrazas, Beatriz Campo Fernandez, Satiro De Oliveira, Theodore B. Moore, Alan K. Ikeda, Barbara C. Engel, Gregory M. Podsakoff, Roger P. Hollis, Augustine Fernandes, Connie Jackson, Sally Shupien, Suparna Mishra, Alejandra Davila, Jack Mottahedeh, Andrej Vitomirov, Wenzhao Meng, Aaron M. Rosenfeld, Aoife M. Roche, Pascha Hokama, Shantan Reddy, John Everett, Xiaoyan Wang, Eline T. Luning Prak, Kenneth Cornetta, Michael S. Hershfield, Robert Sokolic, Suk See De Ravin, Harry L. Malech, Frederic D. Bushman, Fabio Candotti, Donald B. Kohn
Journal: Blood
Blood (2021) 138 (15): 1304–1316.
https://doi.org/10.1182/blood.2020010260
Published: 2021
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Michael D. Tarantino, Amy Geddis, Michael F. Guerrera, Alan K. Ikeda, Kun Nie, Janet Franklin, Melissa Eisen
Journal: Blood
Blood (2014) 124 (21): 4184.
https://doi.org/10.1182/blood.V124.21.4184.4184
Published: 2014
Journal Articles

Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Michael D. Tarantino, MD, James B. Bussel, MD, Amy Geddis, MD, Michael F. Guerrera, MD, Alan K. Ikeda, MD, Kun Nie, PhD, Melissa Eisen, MD
Journal: Blood
Blood (2013) 122 (21): 3530.
https://doi.org/10.1182/blood.V122.21.3530.3530
Published: 2013
Journal Articles

A Small Molecule Inhibitor Targeting CREB and CBP Inhibits Proliferation of AML Cells In Vitro and In Vivo ,

Grace I Aldana-Masangkay, Graduate Student, Bryan Mitton, M.D., Ph.D., Alan K Ikeda, M.D., Kazunari Yamada, M.D., Ph.D., Bingbing Li, Ph.D., Qiuhua Fan, Ph.D., Elliot Landaw, M.D., Ph.D., Xiangshu Xiao, Ph.D., Kathleen M Sakamoto, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3607.
https://doi.org/10.1182/blood.V118.21.3607.3607
Published: 2011
Journal Articles

Tubacin, An Inhibitor of HDAC6, Induces Apoptosis of Acute Lymphoblastic Leukemia Cells in Vitro and in Vivo through a Na+/K+ATPase-Dependent Pathway.

Agustin Rodriguez-Gonzalez, Ph.D., Tiffany Simms-Waldrip, M.D., Alan K. Ikeda, M.D., Tara Lin, M.D., Brett Lomenick, Grace Aldana-Masangkay, Ralph Mazitschek, Ph.D., James Bradner, Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1923.
https://doi.org/10.1182/blood.V112.11.1923.1923
Published: 2008
Journal Articles

Targeting Histone Deacetylase 6 and the Aggresome Pathway in Acute Lymphoblastic Leukemia Cells.

Augustin Rodriguez-Gonzalez, PhD, James Ch’ng, Alan K. Ikeda, M.D., Tara Lin, M.D., Bita Bahrami, Ralph Mazitschek, Ph.D., James E. Bradner, M.D., Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1602.
https://doi.org/10.1182/blood.V110.11.1602.1602
Published: 2007
Journal Articles

Targeting FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia.

Alan K. Ikeda, MD, Dejah Judelson, Junling Li, Ru Qi Wei, Paul Tapang, Steven K. Davidsen, Ph.D., Dan H. Albert, Ph.D., Keith B. Glaser, Ph.D., Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 912.
https://doi.org/10.1182/blood.V110.11.912.912
Published: 2007